After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NYSE and operates within the Medical Instruments & Supplies industry segment. The current market capitalization of Resmed Inc. is $25.74B. A total of 0.59 million shares were traded on the day, compared to an average of 1.08M shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, RMD has seen 11 BUY and 21 SELL insider trades, representing the acquisition of 23,284 and the disposition of 25,657 shares. Over the last 12 months, there were 26 BUYs and 59 SELLs from insiders. Insiders purchased 100,607 shares during that period but sold 132,725.
In the most recent transaction, Sandercock Brett sold 3,000 shares of RMD for 152.62 per share on Nov 27. After the transaction, the Chief Financial Officer now owns 92,962 company shares. In a previous transaction on Nov 15, Farrell Michael J. sold 5,678 shares at 152.04 per share. RMD shares that Chief Executive Officer owns now total 440,986.
Among the insiders who sold shares, Rider Michael J disposed of 25 shares on Nov 01 at a per-share price of $143.42. This resulted in the Global General Counsel holding 7,358 shares of RMD after the transaction. In another insider transaction, Farrell Michael J. sold 5,675 shares at $140.70 per share on Oct 16. Company shares held by the Chief Executive Officer now total 449,360.
Dividend
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Resmed Inc. pays an annual dividend of $1.95, resulting in a dividend yield of 1.11%, and it has a price to earnings (P/E) ratio of 28.46. RMD’s most recent ex-dividend date was 11/8/2023 when it declared a $0.48 quarterly dividend that was paid in cash on 12/14/2023. Previously, the company paid the dividend on 9/21/2023 with an ex-dividend date of 8/16/2023. The RMD stock dividend was $0.48 per share in cash.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for RMD in the last 3 months, the mean price target is $194.02 with high estimates of $265.95 and low estimates of $158.00. In terms of 52-week highs and lows, RMD has a high of $243.52 and a low of $132.24.
As of this writing, RMD has an earnings estimate of $1.79 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of $1.9 per share and a lower estimate of $1.68. The company reported an EPS of $1.6 in the last quarter, which was -5.30% lower than expectations of $1.69.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RMD’s latest balance sheet shows that the firm has $273.71M in Cash & Short Term Investments as of fiscal 2022. There were $917.55M in debt and $689.30M in liabilities at the time. Its Book Value Per Share was $28.90, while its Total Shareholder’s Equity was $3.36B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RMD is Buy with a score of 4.23.
